Alsamara Issam, Ogilvie Lesley, Sudbrak Ralf, Brand Angela
Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Director of the Global AMR R&D Hub Secretariat, Global Antimicrobial Resistance Research and Development Hub, Berlin, Germany.
OMICS. 2023 Dec;27(12):570-580. doi: 10.1089/omi.2023.0049. Epub 2023 Oct 18.
One Health (OH) offers conceptual and applied prospects to advance planetary health and integrative biology in the 21st century. For example, The World Health Organization (WHO) has declared antimicrobial resistance (AMR) one of humanity's top 10 health threats worldwide (AMR). The AMR research, as seen through the OH lens, recognizes the interdependence and the coproduction of the health of humans, nonhuman animals, and the environment (the OH triad). Moreover, research and development (R&D) is required to generate potential solutions to prevent, diagnose, and treat infections and control the spread and emergence of AMR. However, it is still unclear how well the OH approach is integrated into current AMR R&D. In this study, we present a systematic review on the OH funding landscape for cross-sectoral AMR R&D, and its alignment/gaps with the current global strategic agenda on AMR. A systematic literature review was conducted using public databases covering the period between January 2015 and May 2022. We included the studies and reviews on AMR encompassing more than one sector of the OH triad. Out of the 777 included studies, 475 (61%) encompassed the three OH sectors. A key finding of the present systematic review is that the environment was the most neglected sector in the OH triad. AMR surveillance, transmission, and interventions are the most commonly studied priority topics. In addition, both cross-sectoral AMR literature and investments have been increasing since 2017. The operational aspect of AMR is the most researched and funded area. However, certain priority topics in the strategic research and innovation agenda of the Joint Programming Initiative on AMR are underrepresented in OH AMR research, such as diagnosis and therapeutics. To the best of authors' knowledge, this is the first study that systematically reviews the cross-sectoral literature on AMR, classifies it, and aligns and contextualizes it in regard to the funding landscape of AMR. This systematic review identifies neglected areas in AMR R&D and could serve as critical information for policymaking so as to realize the objectives of the Global Action Plan on AMR. Going forward, more cross-sectoral AMR research and funding are needed. As integrative biology and omics systems science are poised to benefit from a rapprochement with the OH lens, the present article highlights the AMR research and funding landscapes.
“同一健康”(OH)为推动21世纪的地球健康和整合生物学提供了概念和应用前景。例如,世界卫生组织(WHO)已将抗菌药物耐药性(AMR)列为全球人类面临的十大健康威胁之一(AMR)。从“同一健康”的视角来看,AMR研究认识到人类、非人类动物和环境的健康(“同一健康”三元组)之间的相互依存关系以及共同作用。此外,需要开展研究与开发(R&D)以生成预防、诊断和治疗感染以及控制AMR传播和出现的潜在解决方案。然而,目前尚不清楚“同一健康”方法在当前AMR研发中的整合程度如何。在本研究中,我们对跨部门AMR研发的“同一健康”资金状况及其与当前全球AMR战略议程的一致性/差距进行了系统综述。使用涵盖2015年1月至2022年5月期间的公共数据库进行了系统的文献综述。我们纳入了涉及“同一健康”三元组多个部门的AMR研究和综述。在纳入的777项研究中,475项(61%)涵盖了“同一健康”的三个部门。本系统综述的一个关键发现是,环境是“同一健康”三元组中最被忽视的部门。AMR监测、传播和干预是最常研究的优先主题。此外,自2017年以来,跨部门AMR文献和投资一直在增加。AMR的运营方面是研究和资金投入最多的领域。然而,AMR联合规划倡议战略研究与创新议程中的某些优先主题在“同一健康”AMR研究中的代表性不足,如诊断和治疗。据作者所知,这是第一项系统综述AMR跨部门文献、对其进行分类并使其与AMR资金状况保持一致并置于相应背景下的研究。本系统综述确定了AMR研发中被忽视的领域,并可为决策提供关键信息,以实现《AMR全球行动计划》的目标。展望未来,需要更多的跨部门AMR研究和资金投入。由于整合生物学和组学系统科学有望从与“同一健康”视角的融合中受益,本文重点介绍了AMR研究和资金状况。